Progressive Age-Related Cognitive Decline in Tau Mice

被引：36

作者：

Van der Jeugd, Ann ^{[1
]}

Vermaercke, Ben ^{[1
]}

Derisbourg, Maxime ^{[2
,3
]}

Lo, Adrian C. ^{[1
]}

Hamdane, Malika ^{[2
,3
]}

Blum, David ^{[2
,3
,4
]}

Buee, Luc ^{[2
,3
,4
]}

D'Hooge, Rudi ^{[1
]}

机构：

[1] Univ Leuven, Fac Psychol & Educ Sci, Lab Biol Psychol, Louvain, Belgium

[2] Univ Lille Nord France, UDSL, Lille, France

[3] INSERM, Jean Pierre Aubert Res Ctr, IMPRT, U837, F-59045 Lille, France

[4] CHRU Lille, CMRR, F-59037 Lille, France

来源：

JOURNAL OF ALZHEIMERS DISEASE | 2013年 / 37卷 / 04期

关键词：

aging; learning; memory; tauopathy; transgenic model; AMYLOID PRECURSOR PROTEIN; TRANSGENIC MOUSE MODEL; LONG-TERM POTENTIATION; MORRIS WATER MAZE; ALZHEIMERS-DISEASE; SYNAPTIC-TRANSMISSION; MEMORY DEFICITS; DEPENDENT IMPAIRMENT; ODOR DISCRIMINATION; HIPPOCAMPAL-NEURONS;

D O I：

10.3233/JAD-130110

中图分类号：

Q189 [神经科学];

学科分类号：

071006 ;

摘要：

Age-related cognitive decline and neurodegenerative diseases are a growing challenge for society. Accumulation of tau pathology has been proposed to partially contribute to these impairments. This study provides a behavioral characterization during aging of transgenic mice bearing tau mutations. THY-Tau22 mice were evaluated at ages wherein tau neuropathology in this transgenic mouse model is low (3-4 months), moderate (6-7 months), or extensive (>9 months). Spatial memory was found to be impaired only after 9 months of age in THY-Tau22 mice, whereas non-spatial memory was affected as early as 6 months, appearing to offer an opportunity for assessing potential therapeutic agents in attenuating or preventing tauopathies through modulation of tau kinetics.

引用

页码：777 / 788

页数：12

共 50 条

[31] Cognitive decline associated with pathological burden in primary age-related tauopathy
Jefferson-George, Kyra S.
Wolk, David A.
Lee, Edward B.
McMillan, Corey T.
ALZHEIMERS & DEMENTIA, 2017, 13 (09) : 1048 - 1053
[32] Molecular aspects of age-related cognitive decline: the role of GABA signaling
McQuail, Joseph A.
Frazier, Charles J.
Bizon, Jennifer L.
TRENDS IN MOLECULAR MEDICINE, 2015, 21 (07) : 450 - 460
[33] Metformin, age-related cognitive decline, and brain pathology
Sood, Ajay
Capuano, Ana Werneck
Wilson, Robert Smith
Barnes, Lisa Laverne
Kapasi, Alifiya
Bennett, David Alan
Arvanitakis, Zoe
NEUROBIOLOGY OF AGING, 2024, 133 : 99 - 106
[34] Age-related cognitive decline in patients with mood disorders
Gualtieri, C. Thomas
Johnson, Lynda G.
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY, 2008, 32 (04) : 962 - 967
[35] When does age-related cognitive decline begin?
Salthouse, Timothy A.
NEUROBIOLOGY OF AGING, 2009, 30 (04) : 507 - 514
[36] Age-related cognitive decline as a function of daytime testing
Puiu, Andrei Alexandru
AGING NEUROPSYCHOLOGY AND COGNITION, 2017, 24 (03) : 333 - 344
[37] Polygenic predictors of age-related decline in cognitive ability
Ritchie, Stuart J.
Hill, W. David
Marioni, Riccardo E.
Davies, Gail
Hagenaars, Saskia P.
Harris, Sarah E.
Cox, Simon R.
Taylor, Adele M.
Corley, Janie
Pattie, Alison
Redmond, Paul
Starr, John M.
Deary, Ian J.
MOLECULAR PSYCHIATRY, 2020, 25 (10) : 2584 - 2598
[38] Cognitive training of mice attenuates age-related decline in associative learning and behavioral flexibility
Attalla, Dalia
Schatz, Alexej
Stumpenhorst, Katharina
Winter, York
FRONTIERS IN BEHAVIORAL NEUROSCIENCE, 2024, 18
[39] Investigation of age-related cognitive decline using mice as a model system: Neurophysiological correlates
Murphy, Geoffrey G.
Shah, Vaibhavi
Hell, Johannes W.
Silva, Alcino J.
AMERICAN JOURNAL OF GERIATRIC PSYCHIATRY, 2006, 14 (12) : 1012 - 1021
[40] Investigation of age-related cognitive decline using mice as a model system: Behavioral correlates
Murphy, Geoffrey G.
Rahnama, Nancy P.
Silva, Alcino J.
AMERICAN JOURNAL OF GERIATRIC PSYCHIATRY, 2006, 14 (12) : 1004 - 1011

← 1 2 3 4 5 →